Disease-model Correction
Disease-Model Correction is a research contribution in therapeutic genome editing that consists of a method, model, framework, or dataset designed to rectify pathogenic genetic alterations in cellular or organismal models of disease, thereby restoring phenotypic and molecular features toward a healthy state.
13
Publications
445
Citations
95
Authors
60
Institutions
Publications per year
2017–2026
6
13
1–5 of 13
95
1
h-index
1
h-index
National Institute of Environmental Health Sciences, United States
1 publications · 15 citations
1
h-index
1
h-index
1
h-index
1–5 of 95
60
Eli Lilly (United States)
Indianapolis, United States
2 h-index
2 publications
37 citations
Ulsan College
Ulsan, South Korea
1 h-index
6 publications
114 citations
Technische Universität Dresden
Dresden, Germany
1 h-index
1 publications
12 citations
Istituti di Ricovero e Cura a Carattere Scientifico
Rome, Italy
1 h-index
3 publications
99 citations
Columbia University
New York, United States
1 h-index
11 publications
143 citations

Johns Hopkins Medicine
Baltimore, United States
1 h-index
2 publications
376 citations

National and Kapodistrian University of Athens
Athens, Greece
1 h-index
1 publications
12 citations
Humanitas University
Rozzano, Italy
1 h-index
2 publications
66 citations
1–8 of 60
1 publications · 18 citations
1
h-index
1 publications · 13 citations
1
h-index
1 publications · 12 citations
1
h-index
1 publications · 19 citations
1
h-index
1 publications · 14 citations
1
h-index
1–5